Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Becton, Dickinson und Company (BD) hat das Elyra Thulium Fiber Laser (TFL) System vorgestellt, ein fortschrittliches Lasersystem in seinem Portfolio für die Behandlung von Nierensteinen. Das System soll die Effizienz, Versatility und den Arbeitsablauf bei der urologischen Steinbehandlung und weichen Gewebeprozessen verbessern.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

First Eagle Investment hat kürzlich das 13F-File für das erste Quartal 2026 eingereicht und somit Einblicke in seine Investitionsstrategie während dieser Periode gegeben. First Eagle ist ein unabhängiger Vermögensverwalter mit einer Geschichte, die bis ins Jahr 1864 zurückreicht...

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Der Flexible Endoskop-Markt wird als wachsende Branche betrachtet. Die Marktdynamik wird von verschiedenen Faktoren beeinflusst, darunter die zunehmende Nachfrage nach minimal-invasiven Eingriffen, die Entwicklung neuer Technologien und die Wettbewerbsstrategien der Hersteller. Die wichtigsten Spieler im Markt sind Olympus Corporation, Cook Medical Inc., Becton Dickinson and Company und Boston Scientific Corporation. Der Bericht bietet eine umfassende Analyse des Marktes, einschließlich der Marktdynamik, der Trends und Prognosen für die Zukunft.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Gesundheitsunternehmen haben dieses Wochenende starke Ergebnisse präsentiert, wobei 18 von 20 Unternehmen ihre EPS-Schätzungen übertroffen und 15 ihre Umsatzerwartungen überboten haben. Die resiliente Nachfrage in der Pharmabranche, Gesundheitsdienstleistungen, medizinischen Geräten und Lebenswissenschaften hat die Druckpunkte bei Margen und Kostenerstattung ausgeglichen.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Die neue Vorsitzende Ivy Parks ist die Präsidentin von BD (Becton, Dickinson und Company) Kanada. Sie leitet eine kanadische Organisation mit etwa 400 Mitarbeitern, die sich für die Verbesserung der Gesundheitsversorgung einsetzt. Die neuen Vorstandsmitglieder sind Brigid Buckingham (GE Healthcare), André Côté (Dexcom Canada), Luz Herrera (Abbott), Ken Hughes (Microbix Biosystems Inc.), Patrick Hupé (Edwards Lifesciences Inc.), Greg LeBlanc (Cook Medical Inc.), Mark Newson (Alcon Canada) und Connie Wong (Intuitive).

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Company Logo

The global microbiology testing market is set to reach USD 10.09 billion by 2031, growing from USD 7.79 billion in 2026 at a CAGR of 5.3%. Growth is driven by rising contamination risks in food, water, and environmental sectors, along with advances in testing technologies. Pharmaceutical & biotech companies dominate the market due to stringent regulations for contamination control and product safety. The bacterial products segment holds the largest share, necessitating continual bacterial testing across industries. The Asia Pacific is the fastest-growing market, propelled by industrialization and healthcare investments, while North America remains the largest market, supported by regulatory frameworks and technological adoption. Major players include bioMérieux, Thermo Fisher Scientific, Merck KGaA, and Becton Dickinson.

Microbiology Testing MarketMicrobiology Testing Market·GlobeNewswire Inc.

Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Microbiology Testing Market by Product, Technology, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The global microbiology testing market is set to expand significantly, projecting growth from USD 7.79 billion in 2026 to USD 10.09 billion by 2031, with a 5.3% CAGR.

This growth is driven by contamination risks in food, water, and environmental sectors, heightened industrial output, and technological advancements in testing. An emphasis on contamination control, regulatory adherence, and innovative rapid testing is increasing demand for accurate microbiology solutions. Concerns over the cost and variability of testing methods may pose challenges, yet continuous improvements and widespread industry adoption are anticipated to sustain expansion.

The pharmaceutical & biotech segment is expected to dominate the market.

This sector, among the largest consumers of microbiology testing, underscores the need for contamination control, safety, and compliance, especially in drug production and biotech research. Rigorous microbial testing is mandated by stringent bodies like the FDA and EMA across all production stages, ensuring sterility and quality. The prevalence of diseases and the necessity for novel treatments amplify the demand for these solutions.

The bacterial products segment holds the largest market share.

The focus on bacterial pathogens stems from their prevalence in contamination across industries. From food and beverage to water treatment, bacterial testing is crucial for maintaining safety and compliance. Established methods for bacterial pathogen detection, bolstered by regulatory requirements, cement this segment's prominence.

Story Continues

Asia Pacific projected to be the fastest-growing region.

Rapid industrialization, heightened healthcare investment, and contamination control initiatives are accelerating Asia Pacific's market growth. The region's burgeoning food and beverage, water treatment, and environmental sectors necessitate extensive microbiological testing. Improved healthcare infrastructure and awareness, alongside governmental regulations and technological adoption, support market trends.

Meanwhile, North America maintains its market leadership due to robust regulatory frameworks driving testing demand. The region's adoption of advanced, automated testing solutions enhances operational accuracy. Diverse sectors such as pharmaceuticals and biotechnology rely on robust microbiology testing, supported by an established healthcare and industrial infrastructure.

Key Attributes:

Report Attribute Details No. of Pages 321 Forecast Period 2026 - 2031 Estimated Market Value (USD) in 2026 $7.79 Billion Forecasted Market Value (USD) by 2031 $10.09 Billion Compound Annual Growth Rate 5.3% Regions Covered Global

Key Topics Covered:

Market Dynamics

Drivers

Technological Advancements in Rapid Microbiology Testing Increased Funding for R&D Rising Food Recalls due to Non-Compliant Food Products Rising Demand from Cosmetics & Personal Care Industry

Restraints

Complexity in Testing Techniques High Capital Investments and Low Cost-Benefit Ratio

Opportunities

Popularity of Digital and Automated Testing Platforms Technological Advancements in Testing Industry

Challenges

Operational Barriers Increasing Cost of Procuring Microbiology Testing Equipment

Company Profiles

Biomerieux Thermo Fisher Scientific Inc. Merck KGaA Becton, Dickinson and Company (Bd) Neogen Corporation Qiagen Bio-Rad Laboratories, Inc. Bruker Shimadzu Corporation Charles River Laboratories Eurofins Scientific Idexx Other Players Hardy Diagnostics Charm Sciences Microbiologics Liofilchem S.R.L. R-Biopharm Romer Labs Division Holding Hygiena LLC Himedia Laboratories Condalab E&O Laboratories Ltd. Mast Group Ltd. Medical Wire & Equipment Hach

For more information about this report visit https://www.researchandmarkets.com/r/tdh6dk

About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

Microbiology Testing Market

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Zusammenfassung

Becton, Dickinson and Company (BD), ein führender Anbieter von Medizintechnik, hat kürzlich die Einführung seiner BD Pyxis Pro Dispensing Solution und der BD Incada Connected Care Plattform in Europa angekündigt. Dieser Schritt stellt einen wichtigen Schritt in BD’s Strategie dar, um die Medikamentenverwaltung in Krankenhäusern zu modernisieren. Das Herzstück der Innovation liegt in der Kombination von automatischer Dispensing mit KI-gestützten Analysen, mit dem Ziel, Arbeitsabläufe zu optimieren, Fehler zu reduzieren und Klinikerinnen und Kliniker zu befähigen, sich auf die Patientenversorgung zu konzentrieren.

Die Einführung wird als potenzielles Marktumfeld angesehen, obwohl der Aktienkurs des Unternehmens kurz nach der Ankündigung leicht gesunken ist. Der anfängliche Rückgang von 1,2 % spiegelt die Reaktion der Anleger auf die Nachricht wider, insbesondere unter Berücksichtigung der Gesamtperformance des Unternehmens – die hinter dem S&P 500 und der breiteren Gesundheitsbranche zurückbleibt.

Langfristig wird BD’s Strategie ihre Wettbewerbsposition im schnell wachsenden digitalen Gesundheitswesen stärken. Die Integration von Automatisierung, KI und Cloud-Infrastruktur ermöglicht es Krankenhäusern, mehr Effizienz zu erzielen, die Einhaltung von Vorschriften zu gewährleisten und letztendlich die Patientenergebnisse zu verbessern. Dies schafft einen wiederkehrenden Umsatzstrom durch Software, Analysen und Support-Dienste. Die Marktkapitalisierung von BD beträgt 44 Milliarden US-Dollar.

Die BD Pyxis Pro Dispensing Solution ist für einen schnellen, zuverlässigen Medikamentenbezug am Ort der Versorgung konzipiert. Ihr anpassungsfähiges Design maximiert die Lagerkapazität und kann sowohl gekühlte als auch Raumtemperatur-Medikamente aufnehmen. Verbesserte Sicherheitsfunktionen – einschließlich RFID-Scanning, Barcode-Lesegeräten und beleuchteten Regalen – rationalisieren die Verwaltung von kontrollierten Substanzen.

Dazu kommt die Erweiterung der BD Incada Analytics Plattform in Europa. Bereits in den USA erfolgreich, bietet diese Plattform mithilfe von KI einen umfassenden Überblick über den Medikamentenbestand in Krankenhäusern. Klinikerinnen und Kliniker können mithilfe von benutzerdefinierten Dashboards und sprachgesteuerten Suchwerkzeugen Muster im Medikamentengebrauch identifizieren, Verschwendung minimieren und die betriebliche Effizienz verbessern. Die Plattform basiert auf Amazon Web Services (AWS) und nutzt die Technologie des European Sovereign Cloud, um Datenschutzbedenken auszuräumen und die Einhaltung der Vorschriften zu gewährleisten.

BD zielt auf einen breiten europäischen Markt ab und unterstützt 15 Sprachen und setzt auf eine schrittweise Einführung. Dieser ehrgeizige Ansatz positioniert BD als Schlüsselspieler bei der digitalen Transformation im europäischen Gesundheitswesen, wobei der Schwerpunkt auf sicherere, effizientere und patientenzentrierte Versorgung liegt.

Der Markt für Medikamentenmanagement-Systeme wird voraussichtlich deutlich wachsen und 2026 9,27 Milliarden US-Dollar erreichen, mit einer jährlichen Wachstumsrate von 8,9 % bis 2034. Dieses Wachstum wird durch Faktoren wie die zunehmende Prävalenz chronischer Krankheiten, die Notwendigkeit, Medikamentenfehler zu reduzieren, die Akzeptanz von KI- und digitalen Technologien sowie regulatorischen Druck zur Förderung der Patientensicherheit angetrieben.

Neben der Hauptveröffentlichung hat BD kürzlich die CE-Marke für den Revello Vascular Covered Stent erhalten, was sein Portfolio im Bereich der peripheren Gefäße weiter ausbaut und seine Präsenz auf dem wachsenden Markt zur Behandlung der peripheren Arteriosklerose stärkt.

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 112 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

This Week’s Ratings Changes:

Upgraded: Strong to Very Strong

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AMAT Applied Materials, Inc. A B A APA APA Corporation A C A BWXT BWX Technologies, Inc. A B A CACI CACI International Inc Class A A C A CMI Cummins Inc. A C A DINO HF Sinclair Corporation A C A EME EMCOR Group, Inc. A B A GOOG Alphabet Inc. Class C A B A HTHT H World Group Limited Sponsored ADR A B A JBL Jabil Inc. A B A LMT Lockheed Martin Corporation A B A MPC Marathon Petroleum Corporation A B A MTSI MACOM Technology Solutions Holdings, Inc. A B A NVMI Nova Ltd. A C A NVT nVent Electric plc A B A VIK Viking Holdings Ltd A B A WDS Woodside Energy Group Ltd Sponsored ADR A B A XOM Exxon Mobil Corporation A C A

Downgraded: Very Strong to Strong

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AGI Alamos Gold Inc. B A B APH Amphenol Corporation Class A A B B BIP Brookfield Infrastructure Partners L.P. A B B CLH Clean Harbors, Inc. A C B CNP CenterPoint Energy, Inc. A C B COR Cencora, Inc. A C B DG Dollar General Corporation A B B DTM DT Midstream, Inc. A C B FNV Franco-Nevada Corporation B B B GFI Gold Fields Limited Sponsored ADR A B B IX ORIX Corporation Sponsored ADR A B B MCK McKesson Corporation A C B NTR Nutrien Ltd. A C B UTHR United Therapeutics Corporation A C B VTR Ventas, Inc. A B B

Upgraded: Neutral to Strong

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade COP ConocoPhillips B D B CQP Cheniere Energy Partners, L.P. B B B CTRA Coterra Energy Inc. B C B DAL Delta Air Lines, Inc. B C B GMED Globus Medical Inc Class A B B B HLT Hilton Worldwide Holdings Inc. B D B IHG InterContinental Hotels Group PLC Sponsored ADR B C B LH Labcorp Holdings Inc. B C B LNG Cheniere Energy, Inc. B B B LVS Las Vegas Sands Corp. B B B MAR Marriott International, Inc. Class A B D B MRNA Moderna, Inc. B C B MS Morgan Stanley B B B NIO NIO Inc. Sponsored ADR Class A B B B NUE Nucor Corporation B C B PSTG Everpure, Inc. Class A C B B RDDT Reddit, Inc. Class A C B B TPL Texas Pacific Land Corporation B C B

Downgraded: Strong to Neutral

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AEE Ameren Corporation B C C AGNC AGNC Investment Corp. C B C ALNY Alnylam Pharmaceuticals, Inc C C C ARGX argenx SE Sponsored ADR C C C BUD Anheuser-Busch InBev SA/NV Sponsored ADR C C C COST Costco Wholesale Corporation C C C CVS CVS Health Corporation C B C ELS Equity LifeStyle Properties, Inc. C C C IRM Iron Mountain, Inc. C C C JBS JBS N.V. Class A C C C LLY Eli Lilly and Company C B C LYV Live Nation Entertainment, Inc. B D C MLM Martin Marietta Materials, Inc. B D C MSI Motorola Solutions, Inc. C C C NLY Annaly Capital Management, Inc. C B C NWG NatWest Group Plc Sponsored ADR C B C PM Philip Morris International Inc. B C C REG Regency Centers Corporation C B C RIVN Rivian Automotive, Inc. Class A B D C TKO TKO Group Holdings, Inc. Class A B D C TLN Talen Energy Corp B D C UL Unilever PLC Sponsored ADR C C C WEC WEC Energy Group Inc B C C

Upgraded: Weak to Neutral

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AEG Aegon Ltd. Sponsored ADR D C C AIZ Assurant, Inc. C C C ARM ARM Holdings PLC Sponsored ADR C C C COF Capital One Financial Corp D C C DECK Deckers Outdoor Corporation D B C DXCM DexCom, Inc. D B C ENTG Entegris, Inc. C C C FTV Fortive Corp. D C C IR Ingersoll Rand Inc. D C C ISRG Intuitive Surgical, Inc. D C C NXPI NXP Semiconductors NV D C C TFC Truist Financial Corporation C C C TU TELUS Corporation C D C WSM Williams-Sonoma, Inc. C C C

Downgraded: Neutral to Weak

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade ADSK Autodesk, Inc. D B D AMT American Tower Corporation D C D AZO AutoZone, Inc. D D D BDX Becton, Dickinson and Company D C D BJ BJ's Wholesale Club Holdings, Inc. D C D CTAS Cintas Corporation D C D EXR Extra Space Storage Inc. D C D FMS Fresenius Medical Care AG Sponsored ADR D B D HDB HDFC Bank Limited Sponsored ADR F C D LOW Lowe's Companies, Inc. D D D MSFT Microsoft Corporation D B D PSA Public Storage D C D PTC PTC Inc. D B D RBLX Roblox Corp. Class A D C D RDY Dr. Reddy's Laboratories Ltd. Sponsored ADR D C D RSG Republic Services, Inc. D C D SCI Service Corporation International D C D SJM J.M. Smucker Company D C D TSN Tyson Foods, Inc. Class A D D D TTWO Take-Two Interactive Software, Inc. D B D

Upgraded: Very Weak to Weak

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade Z Zillow Group, Inc. Class C F C D

Downgraded: Weak to Very Weak

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AMH American Homes 4 Rent Class A F C F BEKE KE Holdings, Inc. Sponsored ADR Class A F D F MKC McCormick & Company, Incorporated F C F

To stay on top of my latest stock ratings, plug your holdings into Stock Grader, my proprietary stock screening tool. But, you must be a subscriber to one of my premium services.

Story Continues

To learn more about my premium service, Growth Investor, and get my latest picks, go here. Or, if you are a member of one of my premium services, you can go here to get started.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Sincerely,An image of a cursive signature in black text.

Louis Navellier

Editor, Market 360

The post ExxonMobil Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks appeared first on InvestorPlace.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Stock Grader recommendations for 112 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

This Week’s Ratings Changes:

Upgraded: Strong to Very Strong

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AMAT Applied Materials, Inc. A B A APA APA Corporation A C A BWXT BWX Technologies, Inc. A B A CACI CACI International Inc Class A A C A CMI Cummins Inc. A C A DINO HF Sinclair Corporation A C A EME EMCOR Group, Inc. A B A GOOG Alphabet Inc. Class C A B A HTHT H World Group Limited Sponsored ADR A B A JBL Jabil Inc. A B A LMT Lockheed Martin Corporation A B A MPC Marathon Petroleum Corporation A B A MTSI MACOM Technology Solutions Holdings, Inc. A B A NVMI Nova Ltd. A C A NVT nVent Electric plc A B A VIK Viking Holdings Ltd A B A WDS Woodside Energy Group Ltd Sponsored ADR A B A XOM Exxon Mobil Corporation A C A

Downgraded: Very Strong to Strong

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AGI Alamos Gold Inc. B A B APH Amphenol Corporation Class A A B B BIP Brookfield Infrastructure Partners L.P. A B B CLH Clean Harbors, Inc. A C B CNP CenterPoint Energy, Inc. A C B COR Cencora, Inc. A C B DG Dollar General Corporation A B B DTM DT Midstream, Inc. A C B FNV Franco-Nevada Corporation B B B GFI Gold Fields Limited Sponsored ADR A B B IX ORIX Corporation Sponsored ADR A B B MCK McKesson Corporation A C B NTR Nutrien Ltd. A C B UTHR United Therapeutics Corporation A C B VTR Ventas, Inc. A B B

Upgraded: Neutral to Strong

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade COP ConocoPhillips B D B CQP Cheniere Energy Partners, L.P. B B B CTRA Coterra Energy Inc. B C B DAL Delta Air Lines, Inc. B C B GMED Globus Medical Inc Class A B B B HLT Hilton Worldwide Holdings Inc. B D B IHG InterContinental Hotels Group PLC Sponsored ADR B C B LH Labcorp Holdings Inc. B C B LNG Cheniere Energy, Inc. B B B LVS Las Vegas Sands Corp. B B B MAR Marriott International, Inc. Class A B D B MRNA Moderna, Inc. B C B MS Morgan Stanley B B B NIO NIO Inc. Sponsored ADR Class A B B B NUE Nucor Corporation B C B PSTG Everpure, Inc. Class A C B B RDDT Reddit, Inc. Class A C B B TPL Texas Pacific Land Corporation B C B

Downgraded: Strong to Neutral

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AEE Ameren Corporation B C C AGNC AGNC Investment Corp. C B C ALNY Alnylam Pharmaceuticals, Inc C C C ARGX argenx SE Sponsored ADR C C C BUD Anheuser-Busch InBev SA/NV Sponsored ADR C C C COST Costco Wholesale Corporation C C C CVS CVS Health Corporation C B C ELS Equity LifeStyle Properties, Inc. C C C IRM Iron Mountain, Inc. C C C JBS JBS N.V. Class A C C C LLY Eli Lilly and Company C B C LYV Live Nation Entertainment, Inc. B D C MLM Martin Marietta Materials, Inc. B D C MSI Motorola Solutions, Inc. C C C NLY Annaly Capital Management, Inc. C B C NWG NatWest Group Plc Sponsored ADR C B C PM Philip Morris International Inc. B C C REG Regency Centers Corporation C B C RIVN Rivian Automotive, Inc. Class A B D C TKO TKO Group Holdings, Inc. Class A B D C TLN Talen Energy Corp B D C UL Unilever PLC Sponsored ADR C C C WEC WEC Energy Group Inc B C C

Upgraded: Weak to Neutral

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AEG Aegon Ltd. Sponsored ADR D C C AIZ Assurant, Inc. C C C ARM ARM Holdings PLC Sponsored ADR C C C COF Capital One Financial Corp D C C DECK Deckers Outdoor Corporation D B C DXCM DexCom, Inc. D B C ENTG Entegris, Inc. C C C FTV Fortive Corp. D C C IR Ingersoll Rand Inc. D C C ISRG Intuitive Surgical, Inc. D C C NXPI NXP Semiconductors NV D C C TFC Truist Financial Corporation C C C TU TELUS Corporation C D C WSM Williams-Sonoma, Inc. C C C

Downgraded: Neutral to Weak

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade ADSK Autodesk, Inc. D B D AMT American Tower Corporation D C D AZO AutoZone, Inc. D D D BDX Becton, Dickinson and Company D C D BJ BJ's Wholesale Club Holdings, Inc. D C D CTAS Cintas Corporation D C D EXR Extra Space Storage Inc. D C D FMS Fresenius Medical Care AG Sponsored ADR D B D HDB HDFC Bank Limited Sponsored ADR F C D LOW Lowe's Companies, Inc. D D D MSFT Microsoft Corporation D B D PSA Public Storage D C D PTC PTC Inc. D B D RBLX Roblox Corp. Class A D C D RDY Dr. Reddy's Laboratories Ltd. Sponsored ADR D C D RSG Republic Services, Inc. D C D SCI Service Corporation International D C D SJM J.M. Smucker Company D C D TSN Tyson Foods, Inc. Class A D D D TTWO Take-Two Interactive Software, Inc. D B D

Upgraded: Very Weak to Weak

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade Z Zillow Group, Inc. Class C F C D

Downgraded: Weak to Very Weak

Symbol Company Name Quantitative Grade Fundamental Grade Total Grade AMH American Homes 4 Rent Class A F C F BEKE KE Holdings, Inc. Sponsored ADR Class A F D F MKC McCormick & Company, Incorporated F C F

To stay on top of my latest stock ratings, plug your holdings into Stock Grader, my proprietary stock screening tool. But, you must be a subscriber to one of my premium services.

Story Continues

To learn more about my premium service, Growth Investor, and get my latest picks, go here. Or, if you are a member of one of my premium services, you can go here to get started.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Sincerely,An image of a cursive signature in black text.

Louis Navellier

Editor, Market 360

The post Morgan Stanley Upgraded, Tyson Foods Downgraded: Updated Rankings on Top Blue-Chip Stocks appeared first on InvestorPlace.

View Comments

Haftungsausschluss: Der Text wurde mit Hilfe einer KI zusammengefasst und übersetzt. Für Aussagen aus dem Originaltext wird keine Haftung übernommen!

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that the FDA has granted 510(k) clearance for its Surgiphor 1000mL antimicrobial irrigation system. The product is the first antimicrobial irrigation solution available in a 1000mL format designed for powered lavage, providing a standardized and OR-ready option to support surgical safety and procedural performance. The Surgiphor 1000mL expands BD’s existing Surgiphor portfolio and enables clinicians to mechanically remove debris and microorganisms from wounds during powered irrigation procedures.

Per management, the FDA clearance further strengthens the company’s leadership in surgical irrigation technologies. The Surgiphor 1000mL antimicrobial irrigation system is designed to deliver consistent and safe irrigation performance, supporting surgical teams in improving procedural efficiency and patient care outcomes.

Likely Trend of BDX Stock Following the News

Shares of BDX have lost 1.6% since the announcement on Monday. Over the past six months, shares of the company declined 10.9% against the industry’s 23.3% growth and the S&P 500’s 6.4% rise.

In the long run, the FDA 510(k) clearance for BD’s Surgiphor 1000mL is expected to strengthen the company’s position in the wound irrigation systems market. By expanding the Surgiphor platform with a larger-volume powered irrigation option, the company can strengthen adoption across hospitals that rely on standardized, ready-to-use solutions to improve surgical outcomes and operational efficiency. The innovation also supports BDX’s broader strategy of expanding its surgery portfolio with integrated solutions that combine devices, consumables and clinical workflow support, which could help drive recurring product demand and strengthen hospital partnerships.

BDX currently has a market capitalization of $49.60 billion.Zacks Investment Research

Image Source: Zacks Investment Research

More on the Surgiphor 1000mL

The Surgiphor 1000mL antimicrobial irrigation system is supplied as a ready-to-use sterile solution, eliminating the need for manual mixing by hospital staff. This design helps reduce preparation time in the operating room while supporting adherence to established safety standards for surgical wound irrigation. Building on the market adoption of the original Surgiphor antimicrobial irrigation system, the 1000mL configuration provides operating room teams with a higher-volume option designed to integrate with existing powered irrigation systems.

Engineered to work with widely used powered lavage devices, the system features a powered-device adapter along with a Y-connector that allows clinicians to switch between saline and Surgiphor solution during procedures. A twist cap is also included to support manual application when needed, providing additional flexibility for different clinical scenarios.

Story Continues

The design incorporates integrated venting to facilitate consistent and uninterrupted fluid flow, while the collapsible bottle structure helps ensure efficient evacuation and easier handling during use. The solution contains terminally sterile PVP-I (povidone-iodine) and forms part of BD’s broader surgical irrigation portfolio, offering terminally sterile PVP-I solutions in multiple volumes and delivery formats.

With the introduction of the 1000mL configuration, the Surgiphor antimicrobial irrigation system portfolio now includes both manual and powered irrigation options, allowing clinicians to choose formats that best align with procedural requirements and operating room workflows.

Industry Prospects Favoring the Market

Going by the data provided by Precedence Research, the wound irrigation systems market is valued at $356.16 million in 2026 and is expected to witness a CAGR of 4.7% through 2035.

Factors like the increasing chronic wound cases and the adoption of advanced, automated devices that improve infection control and healing efficacy are boosting the market’s growth.

Other News

BD recently introduced the BD Vacutainer Urine Complete Cup Kit, a three-tube urine collection system aimed at expanding diagnostic testing from a single specimen. The launch highlights the company’s efforts to improve preanalytical workflows and laboratory efficiency. The kit is designed to preserve specimen integrity, reduce healthcare worker exposure and minimize repeat collections. Its unique third-tube configuration allows additional testing from one sample while eliminating manual transfers, thereby lowering contamination risks and improving operational safety in clinical environments.

In January, BD announced the commercial launch of BD Research Cloud 7.0, advancing its AI strategy in flow cytometry and life sciences research. The release features BD Horizon Panel Maker, an AI-driven tool that automates panel design — an essential step in immunology and oncology experiments to improve data quality and reliability. The cloud-based platform supports collaboration, workflow optimization and laboratory management.

Becton, Dickinson and Company PriceBecton, Dickinson and Company Price

Becton, Dickinson and Company price | Becton, Dickinson and Company Quote

BDX’s Zacks Rank & Key Picks

Currently, BDX carries a Zacks Rank #4 (Sell).

Some top-ranked stocks from the broader medical space are Intuitive Surgical ISRG, Phibro Animal Health PAHC and Cardinal Health CAH.

Intuitive Surgical, sporting a Zacks Rank #1 (Strong Buy) at present, reported fourth-quarter 2025 adjusted earnings per share (EPS) of $2.53, beating the Zacks Consensus Estimate by 12.4%. Revenues of $2.87 billion surpassed the Zacks Consensus Estimate by 4.7%. You can see the complete list of today’s Zacks #1 Rank stocks here.

ISRG has an estimated long-term earnings growth rate of 15.7% compared with the industry’s 14% rise. The company beat earnings estimates in the trailing four quarters, the average surprise being 13.2%.

Phibro Animal Health, currently sporting a Zacks Rank #1, reported second-quarter 2025 adjusted EPS of 87 cents, which surpassed the Zacks Consensus Estimate by 26.1%. Revenues of $373.9 million beat the Zacks Consensus Estimate by 4.7%.

PAHC has an estimated long-term earnings growth rate of 21.5% compared with the industry’s 12.6% rise. The company beat earnings estimates in the trailing four quarters, the average surprise being 20.1%.

Cardinal Health, currently carrying a Zacks Rank #2 (Buy), reported second-quarter fiscal 2026 adjusted EPS of $2.63, which surpassed the Zacks Consensus Estimate by 10%. Revenues of $65.6 billion beat the Zacks Consensus Estimate by 0.9%.

CAH has an estimated long-term earnings growth rate of 15% compared with the industry’s 9.1% rise. The company beat earnings estimates in the trailing four quarters, the average surprise being 9.3%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Becton, Dickinson and Company (BDX) : Free Stock Analysis Report

Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report

Cardinal Health, Inc. (CAH) : Free Stock Analysis Report

Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

View Comments